44,496 Shares in Option Care Health, Inc. (NASDAQ:OPCH) Acquired by Teza Capital Management LLC

Teza Capital Management LLC purchased a new stake in Option Care Health, Inc. (NASDAQ:OPCH) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 44,496 shares of the company’s stock, valued at approximately $1,032,000.

Several other institutional investors have also recently added to or reduced their stakes in the business. Murphy & Mullick Capital Management Corp acquired a new position in shares of Option Care Health during the fourth quarter worth approximately $26,000. UMB Bank n.a. raised its position in Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after buying an additional 346 shares during the last quarter. Signaturefd LLC raised its position in Option Care Health by 487.9% in the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock valued at $28,000 after buying an additional 1,005 shares during the last quarter. Quadrant Capital Group LLC raised its position in Option Care Health by 172.8% in the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company’s stock valued at $40,000 after buying an additional 1,099 shares during the last quarter. Finally, Johnson Financial Group Inc. purchased a new stake in Option Care Health in the 4th quarter valued at $47,000. 98.05% of the stock is owned by institutional investors and hedge funds.

Option Care Health Stock Performance

Shares of NASDAQ OPCH opened at $33.23 on Monday. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The stock’s 50-day moving average is $33.07 and its 200 day moving average is $29.06. The stock has a market cap of $5.44 billion, a price-to-earnings ratio of 27.92, a P/E/G ratio of 2.30 and a beta of 0.76. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping analysts’ consensus estimates of $0.36 by $0.04. The business had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.26 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The business’s quarterly revenue was up 16.3% on a year-over-year basis. During the same period in the previous year, the firm earned $0.26 EPS. On average, sell-side analysts anticipate that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Insider Transactions at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares in the company, valued at $1,495,835.24. The trade was a 40.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 0.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on OPCH shares. UBS Group raised Option Care Health from a “neutral” rating to a “buy” rating and increased their price target for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. JPMorgan Chase & Co. upped their price objective on Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research note on Thursday, March 6th. JMP Securities reiterated a “market outperform” rating and set a $36.00 price target on shares of Option Care Health in a research note on Tuesday, April 22nd. Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and raised their target price for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $38.00 price target on shares of Option Care Health in a report on Wednesday, April 30th. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $35.50.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.